mitoxantrone has been researched along with Cancer of the Vulva in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mitoxantrone displays no activity in patients with advanced carcinoma of the vulva or vagina." | 1.28 | Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study. ( Bundy, BN; Christopherson, WA; Muss, HB, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muss, HB | 1 |
| Bundy, BN | 1 |
| Christopherson, WA | 1 |
1 other study available for mitoxantrone and Cancer of the Vulva
| Article | Year |
|---|---|
Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study.
Topics: Adult; Aged; Aged, 80 and over; Bone Marrow; Carcinoma, Squamous Cell; Female; Humans; Infusions, In | 1989 |